Raymond James & Associates Vascular Biogenics Ltd. Put Options Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VBLT
# of Institutions
2Shares Held
416KCall Options Held
0Put Options Held
0About Vascular Biogenics Ltd.
- Ticker VBLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,348,896
- Description
- Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...